merck keytruda - Search News

News

Verona, Merck and Keytruda

Reuters on MSN · 1d

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

The Wall Street Journal on MSN · 1d

Merck to Buy Verona Pharma in $10 Billion Deal

The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Cancer drug Keytruda maker Merck buys Verona before patent cliff

A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year. Keytruda may also face “ price setting ” from the Inflation Reduction Act in 2026.

1h

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

1d

Merck Faces Multiple Challenges: Will It Steer Through Successfully?

MRK banks on new launches as Keytruda faces a looming patent cliff and Gardasil weakens amid China's demand slump.

1don MSN

Merck to Buy Verona for $10 Billion as Patent Cliff Looms

Merck & Co. agreed to buy respiratory drugmaker Verona Pharma Plc for around $10 billion as part of its ongoing search for ...

20hon MSN

Merck Acquires Verona Pharma for $10B to Support Portfolio with COPD Drug Ohtuvayre Ahead of Keytruda Patent Expiration

Merck & Co. Inc. (NYSE:MRK) is one of the most undervalued NYSE stocks to buy now. On July 9, Merck announced its acquisition ...

1d

Merck will have 'a lot more work to do' after Verona deal

Merck (MRK) is spending about $10 billion to acquire Verona Pharma (VRNA) as the company looks to fill future revenue gaps.

Pharmalittle: We’re reading about Trump’s latest tariff threat, a Merck deal, and lots more

President Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S., but not immediately ...

3d

Merck & Co.: A Pharma Titan At A Discount

Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results